Consumer health is expected to see increased current value growth in 2020. The spread of the COVID-19 pandemic has fuelled growth of immunity-boosting vitamins and dietary supplements, as well as topical germicidals/antiseptics in the year. Sleep aids have also benefited from increased levels of stress and anxiety as a result of COVID-19, whilst sales of gauze, tape and other wound care were driven by consumers using these products to made masks to prevent the spread of the virus.
Consumer Health in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Our reports have been used by over 10K customers, including:
125 pages •
By Euromonitor International
• Dec 2020
2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
94 pages •
By Euromonitor International
• Nov 2020
With Kenyans mired in the COVID-19 pandemic, it is perhaps not surprising that value sales of consumer health products are set to rise in 2020 at a rate higher than those recorded during the review period. Broadly, a pandemic-inspired heightened focus on maintaining/improving health is driving greater interest in over the counter (OTC) health...
106 pages •
By Euromonitor International
• Nov 2020
Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
103 pages •
By Euromonitor International
• Nov 2020
The Malaysian Government implemented the Movement Control Order (MCO) from 18 March to 4 May in an effort to contain the spread of the COVID-19 pandemic in the country. There followed the Conditional Movement Control Order (CMCO) – between 4 May and 10 June, and the Recovery Movement Control Order (RMCO) – between 10 June and 31 August. All...
101 pages •
By Euromonitor International
• Nov 2020
Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than...
126 pages •
By Euromonitor International
• Nov 2020
The outbreak and development of Coronavirus (COVID-19) from early March 2020 halted the economic improvement in the country. Lockdown and other restrictions on business, education and cultural institutions and the population in general fed into rising unemployment, wage cuts and reduced disposable incomes as the government tried to contain...
122 pages •
By Euromonitor International
• Nov 2020
The outbreak of COVID-19 in South Korea is not predicted to increase growth in 2020, with value growth of 3% expected for the year, compared to value growth of 5% recorded in 2019. As South Korea did not have an enforced lockdown, sales were not impacted by high levels of stockpiling that was seen in other countries Consumer Health...
117 pages •
By Euromonitor International
• Nov 2020
The outbreak of Coronavirus (COVID-19) has provided a shock to both the Spanish economy and society and significantly impacted consumer health sales. While Spain has not suffered from obvious shortages of medicines, the stockpiling of certain products, especially analgesics and cough, cold and allergy (hay fever) remedies, has been observed. Consumer...
113 pages •
By Euromonitor International
• Nov 2020
To mitigate the risk of contracting COVID-19 consumers in Japan have been confining themselves to their homes on a more regular basis, while they are also taking a more proactive approach to their health, focusing on prevention over treatment. This has resulted in contrasting fortunes for the various product categories within consumer health....
120 pages •
By Euromonitor International
• Nov 2020
The outbreak of COVID-19 is not expected to increase growth in 2020, with value growth of 2% predicted for the year, compared to value growth of 4% recorded in 2019. Unlike other countries, Sweden did not go into a full lockdown during Q1 and Q2, and this had some impact on the level of stockpiling that took place, which was mainly seen in...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.